Page last updated: 2024-12-07

3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide: a 5-HT(1D) receptor antagonist; RN given refers to HCl salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128017
MeSH IDM0270537

Synonyms (12)

Synonym
3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide
3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide monohydrochloride
benzamide, 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)-, monohydrochloride
DTXSID90169413
3-[3-(dimethylamino)propyl]-4-hydroxy-n-(4-pyridin-4-ylphenyl)benzamide;hydrochloride
gr-55562 dihydrobromide
AKOS040748444
gr-55562 hydrochloride
3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(pyridin-4-yl)phenyl)benzamide hydrochloride
benzamide, 3-[3-(dimethylamino)propyl]-4-hydroxy-n-[4-(4-pyridinyl)phenyl]-, hydrochloride (1:1)
2W3MCW3DHS
benzamide, 3-[3-(dimethylamino)propyl]-4-hydroxy-n-[4-(4-pyridinyl)phenyl]-, monohydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"5 mg/kg) did not modify dose-response curves of the psychostimulant, nor did it affect its ED50 value."( Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats.
Baran, L; Filip, M; Nowak, E; PrzegaliƄski, E,
)
0.13
"5 mg/kg) produced a leftward shift in the cocaine dose-response curve and a decrease in its ED(50) value."( Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
Filip, M; Jungersmith, K; Nowak, E; Papla, I; PrzegaliƄski, E, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (12.00)18.2507
2000's18 (72.00)29.6817
2010's3 (12.00)24.3611
2020's1 (4.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.48 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]